These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. New technologies in gene therapy for inducing immune tolerance in hemophilia A. Borsotti C; Follenzi A Expert Rev Clin Immunol; 2018 Dec; 14(12):1013-1019. PubMed ID: 30345839 [TBL] [Abstract][Full Text] [Related]
52. Genetic engineering for haemophilia A. Gan SU; Kon OL; Calne RY Expert Opin Biol Ther; 2006 Oct; 6(10):1023-30. PubMed ID: 16989584 [TBL] [Abstract][Full Text] [Related]
53. The critical need for postmarketing surveillance in gene therapy for haemophilia. Konkle BA; Recht M; Hilger A; Marks P Haemophilia; 2021 Feb; 27 Suppl 3():126-131. PubMed ID: 32495492 [TBL] [Abstract][Full Text] [Related]
54. Hemophilia gene therapy comes of age. George LA Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):587-594. PubMed ID: 29222308 [TBL] [Abstract][Full Text] [Related]
55. Utilization of a novel Sendai virus vector in ex vivo gene therapy for hemophilia A. Yamaki Y; Fukushima T; Yoshida N; Nishimura K; Fukuda A; Hisatake K; Aso M; Sakasai T; Kijima-Tanaka J; Miwa Y; Nakanishi M; Sumazaki R; Takada H Int J Hematol; 2021 Apr; 113(4):493-499. PubMed ID: 33385293 [TBL] [Abstract][Full Text] [Related]
56. Vectors and strategies for nonviral cancer gene therapy. Pahle J; Walther W Expert Opin Biol Ther; 2016; 16(4):443-61. PubMed ID: 26761200 [TBL] [Abstract][Full Text] [Related]
58. Progress in the use of gene transfer methods to treat genetic blood diseases. Williams DA; Smith FO Hum Gene Ther; 2000 Oct; 11(15):2059-66. PubMed ID: 11044908 [TBL] [Abstract][Full Text] [Related]
59. Adeno-associated viral vectors for the treatment of hemophilia. High KA; Anguela XM Hum Mol Genet; 2016 Apr; 25(R1):R36-41. PubMed ID: 26614390 [TBL] [Abstract][Full Text] [Related]